Antimicrobial activities of new indole derivatives containing 1,2,4-triazole, 1,3,4-thiadiazole and carbothioamide; [1,2,4-triazol, 1,3,4-tiyadiazol ve karbotiyoamit içeren yeni indol türevlerinin antimikrobiyal aktiviteleri]

ArticleAçık Erişim

Özet

Objectives: In new antimicrobial drug development studies, indole and its derivatives create an important class of compounds. In addition, azoles and their derivatives were recognized to be associated with a variety of biologic activities such as antibacterial and antifungal. In this study antimicrobial activities of some indole derivatives mainly substituted with 1,2,4-triazole, 1,3,4-thiadiazole and hydrazinecarbothioamide were investigated to evaluate their efficacy. Materials and Methods: The efficacy of new compounds was evaluated using 2-fold serial dilutions against Staphylococcus aureus, MRSA, Escherichia coli, Bacillus subtilis, Candida albicans, and Candida krusei. Results: The MIC was determined for test compounds and for the reference standards sultamicillin, ampicillin, fluconazole, and ciprofloxacin. Conclusion: The compounds possessed a broad spectrum of activity having MIC values of 3.125-50 µg/mL against the tested microorganisms. This study provides valuable evidence that the indole-triazole derivative compound 3d holds significant promise as a novel antibacterial and antifungal lead compound. © Turk J Pharm Sci, Published by Galenos Publishing House.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/14032Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.4274/tjps.55707Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorShirinzadeh, Hanif
dc.contributor.authorSüzen, Sibel
dc.contributor.authorAltanlar, Nurten
dc.contributor.authorWestwell, Andrew D.
dc.date.accessioned2026-10-18T20:28:49.611383483Z
dc.date.available2026-10-18T20:28:49.611383483Z
dc.date.issued2018
dc.description.abstractObjectives: In new antimicrobial drug development studies, indole and its derivatives create an important class of compounds. In addition, azoles and their derivatives were recognized to be associated with a variety of biologic activities such as antibacterial and antifungal. In this study antimicrobial activities of some indole derivatives mainly substituted with 1,2,4-triazole, 1,3,4-thiadiazole and hydrazinecarbothioamide were investigated to evaluate their efficacy. Materials and Methods: The efficacy of new compounds was evaluated using 2-fold serial dilutions against Staphylococcus aureus, MRSA, Escherichia coli, Bacillus subtilis, Candida albicans, and Candida krusei. Results: The MIC was determined for test compounds and for the reference standards sultamicillin, ampicillin, fluconazole, and ciprofloxacin. Conclusion: The compounds possessed a broad spectrum of activity having MIC values of 3.125-50 µg/mL against the tested microorganisms. This study provides valuable evidence that the indole-triazole derivative compound 3d holds significant promise as a novel antibacterial and antifungal lead compound. © Turk J Pharm Sci, Published by Galenos Publishing House.
dc.description.sponsorshipThe chemical synthesis part of this work was supported by the Scientific and Technological Research Council of Turkey (TUBİTAK) Research and Development Grant 112S599.
dc.identifier.doi10.4274/tjps.55707
dc.identifier.eissn2148-6247
dc.identifier.endpage297
dc.identifier.issn1304-530X
dc.identifier.issue3
dc.identifier.pmcidPMC7227843
dc.identifier.pmid32454672
dc.identifier.scopus2-s2.0-85062059516
dc.identifier.startpage291
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/14032
dc.identifier.volume15
dc.identifier.wosWOS:000450780900008
dc.language.isoen
dc.publisherTurkish Pharmacists Association
dc.relation.ispartofTurkish Journal of Pharmaceutical Sciences
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subject1,2,4-triazole
dc.subject1,3,4-thiadiazole
dc.subjectC. krusei
dc.subjectIndole
dc.subjectMRSA
dc.subject1,2,4 triazole derivative
dc.subject1,3,4 thiadiazole derivative
dc.subjectampicillin
dc.subjectcarbothioamide
dc.subjectciprofloxacin
dc.subjectfluconazole
dc.subjectindole derivative
dc.subjectsultamicillin
dc.subjectunclassified drug
dc.subjectantibacterial activity
dc.subjectantifungal activity
dc.subjectantimicrobial activity
dc.subjectArticle
dc.subjectBacillus subtilis
dc.subjectbacterium culture
dc.subjectCandida albicans
dc.subjectdrug analysis
dc.subjectdrug efficacy
dc.subjectdrug synthesis
dc.subjectEscherichia coli
dc.subjectmethicillin resistant Staphylococcus aureus
dc.subjectminimum inhibitory concentration
dc.subjectnonhuman
dc.subjectPichia kudriavzevii
dc.subjectStaphylococcus aureus
dc.titleAntimicrobial activities of new indole derivatives containing 1,2,4-triazole, 1,3,4-thiadiazole and carbothioamide; [1,2,4-triazol, 1,3,4-tiyadiazol ve karbotiyoamit içeren yeni indol türevlerinin antimikrobiyal aktiviteleri]
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus45
rdl.citation.trdizin2
rdl.citation.wos38
rdl.departmentANKARA ÜNİVERSİTESİ
rdl.departmentYabancı Kurumlar
rdl.departmentERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexTRDIZIN
rdl.source.indexPUBMED
rdl.wos.indexEmerging Sources Citation Index (ESCI)